Atlas
Market PulseSector ViewStocksETFFundsPortfoliosAdmin
Atlas › Stocks › KIMS

KIMS

Krishna Institute of Medical Sciences Limited
Small-capHealthcare ↗

What the six lenses say about KIMS — its relative strength vs the baselines, price & RS trend, the 8-quarter financials, and live filings.

Price
₹813.8
2026-07-10
VWAP · 1Y anchor
₹715
+13.8% from VWAP
P/E · TTM
135.2×
TTM EPS ₹6.0
52-week range
86%
position low→high
RSI(14)
55
momentum

Own sector index

Healthcare ↗
Overweight

1M

+5.5%

3M

+14.9%

1Y

+12.8%

Breadth >EMA21

68%

How KIMS’s own sector index is moving — context for reading the stock’s six lenses.

Six-lens read

What the six lenses say

How the lenses are scored ↗
Strength
5.5
avg conviction decile
Leadership
0/2
active lenses · Tech & Flow
Each lens is a decile within its cap cohort (D10 = top 10%) — no black-box composite. Expand a lens for the real numbers behind it.
LensDecile · Small-cap cohortDRaw
TechnicalD788›

The actual numbers

Price vs VWAP (1y)+13.8%
EMA trend stackUp · 21>50>200
Price vs 200-EMA+15.1%
Price vs 50-EMA+5.3%
RSI(14)55
RS vs Nifty 500 · 3M+19.2%
RS vs sector · 3M+7.6%
52-week range86%
Volume vs 30d avg0.60×
Volume vs 60d avg0.64×
ATR(14) · volatility27.3
Bollinger width · vol contraction0.097
FundamentalD335›

The actual numbers

Return on equity (ROE)11.3%
Return on capital (ROCE)9.3%
Operating margin13.8%
Net margin6.2%
Revenue growth · YoY+28.7%
EPS growth · YoY-67.0%
Debt / equity1.89×

Full 8-quarter history in the financials table below.

ValuationD10›

The actual numbers

P/E (TTM)135.2×
TTM EPS₹6.0
52-week range86%
CatalystD744›

The actual numbers

Earnings & momentum41
Capital actions22
Governance113

Every filing in the corporate-announcements panel below.

FlowD442›

The actual numbers

Promoter holding34.1%
Delivery · 30d avg52.3%
Up/down-day asymmetry-3.3pp
How the decile & conviction are calculated

Decile — each lens’s 0–100 score is ranked against every Small-cap stock in the universe. D10 = top 10% (strongest), D1 = bottom 10%. A decile is simply where this stock sits versus its size-peers on that lens — no weighting, no black box.

Conviction — the average of the two active conviction-lens deciles (Technical & Flow):

( D7 + D4 ) ÷ 2 = 5.5(Technical · Flow)

Fundamental, Catalyst, Valuation and Policy are shown for context but carry weight 0 in the current model, so they are not scored into conviction. Full detail on the methodology page ↗.

Glass box

How the score is built

Click a lens to expand its sub-components, then drill to the actual values. The eye icon on any term explains it.

Conviction score · Highest
83
Conviction score 83/100 · avg-decile strength 5.5/10
Conviction score83/100›
TechnicalD7›
FundamentalD3›
ValuationD1›
CatalystD7›
FlowD4›

Policy

Government policy · Healthcare

Active policies relevant to this sector — flagged as a Red / Amber / Green signal, not scored into the six-lens conviction. The lenses say what the market is doing; policy is context for why.

Tailwind· HIGH impact

PLI Scheme — Pharmaceuticals & API

Production-linked incentive scheme for pharmaceuticals, APIs, and medical devices

Relative strength · always on

Percentage-point spread vs each baseline across six windows. Green = outperforming, red = lagging. Data as of 2026-07-10.

Baseline1D1W1M3M6M12M
Nifty 50
Large-cap anchor
+0.6pp
-2.0pp
+3.4pp
+22.9pp
+37.9pp
+19.5pp
Nifty 500
Broad-market baseline
+0.2pp
-2.1pp
+2.8pp
+19.2pp
+32.9pp
+15.6pp
Sector
Own-sector index
—
—
+1.1pp
+7.6pp
+20.1pp
+1.2pp

From atlas_foundation.technical_daily. Sector row covers 1M–12M (1D/1W not stored).

Trend

Price · EMA 20 / 50 / 200

KIMS daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.

₹ (close)
813.75+7.80

Relative strength

RS vs baseline · rebased to 100

KIMS ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.

RS vs Nifty 500 (=100)
186.72+0.39

TradingView composite technical analysis — multi-timeframe consensus

Quarterly financials

Last 8 quarters from the company’s filings (₹ crore) — revenue, profit, margins and the growth trend.

MetricJun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26
Revenue (₹cr)6887777727978729619981,075
↳ change QoQ—+12.9%-0.6%+3.2%+9.4%+10.2%+3.9%+7.7%
EBITDA (₹cr)184223205198193204199206
EBITDA margin26.7%28.7%26.5%24.8%22.1%21.2%19.9%19.2%
PAT (₹cr)951219310685725233
↳ change QoQ—+26.8%-23.4%+14.6%-19.8%-15.3%-27.8%-36.5%
Net margin13.8%15.5%12.0%13.3%9.8%7.5%5.2%3.1%
EPS (₹)10.822.682.222.541.961.671.331.06
D/E————————
YoY growth · Mar '26Revenue +34.9% YoYPAT -68.9% YoY

Corporate announcements

Filings to the exchange — capital actions, earnings and governance. Most recent first.

  • 19 Jun '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 19 Jun '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 19 Jun '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 16 Jun '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 16 Jun '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 13 Jun '26
    HIGHearnings
    Outcome of Board Meeting
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 11 Jun '26
    MEDIUMgovernance
    Disclosure under SEBI Takeover Regulations
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 5 Jun '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 2 Jun '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 1 Jun '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 22 May '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 20 May '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 18 May '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 16 May '26
    MEDIUMcapital
    Press Release
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 16 May '26
    MEDIUMearnings
    Investor Presentation
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗

…and 5 more.

Ownership

Who holds KIMS

Mutual funds holding KIMS (10)

FundWeightAUM ₹crGrade
Nippon India Small Cap Dir Bns0.64%78,407
Nippon India Small Cap Gr0.64%78,407
Nippon India Small Cap Gr Bns0.64%78,407
SBI Small Cap Fund Reg Gr2.50%40,157
HDFC Small Cap Gr2.18%38,809
Axis Small Cap Fund Reg Gr2.76%27,840
SBI Multicap Reg Gr2.23%23,693
Kotak Small Cap Reg Gr3.68%18,691
HSBC Small Cap Fund Reg Gr0.74%16,877
Axis Flexi Cap Reg Gr3.27%12,625

ETFs holding KIMS (8)

ETFWeightGrade
Groww BSE Hospitals ETF8.75%
Mirae Asset Nifty 500 Healthcare ETF1.49%
Motilal Oswal BSE Healthcare ETF1.28%
Motilal Oswal Nifty Smallcap 250 ETF0.93%
Mirae Asset Nifty Smallcap 250 ETF0.93%
HDFC Nifty Smallcap 250 ETF0.93%
DSP Nifty Smallcap 250 ETF0.92%
Groww Nifty Smallcap 250 ETF0.92%
Show company profile (about, sector, employees, IPO)
Native from atlas_foundation — lens journal, technical_daily, ohlcv_stock; TradingView for the live instrument view. ← Back to Healthcare